Join us in our next event organised under the @genehproject.bsky.social and participate!

We have prepared a very interesting program together with the #CFGBC. You can also participate by submitting your abstract for a poster

Registration Link: cfgbc.mf.uni-lj.si/events/2026c...

New Project Grant Received: Sonogenetics as a central modulator of CAR-T function and lineage commitment - CTGCT As part of our efforts towards the sustainability of the CTGCT and with the goal in mind to develop new gene and cell therapies for cancer and rare diseases, our team members are applying to several g...

The #CTGCT is proud to announce that Assoc. Prof. Dr. Mojca Benčina has received an #ARIS project grant for Project Calcium-switch!

We’re rethinking #CAR-T therapy by using #sonogenetics to "wake up" T cells exactly when and where they’re needed.
ctgct.si/en/objave/ca...

#Immunotherapy

Last reminder to register for this #webinar that we will host where Dr. Thomas Fox will present his latest advances in programmable #T-cell therapies as part of #UCL and #Harvard Medical School

CTGCT Science Talks April - Dr. Thomas Fox - CTGCT On Monday, 13th of April 2026, 2:00 PM (Ljubljana/Berlin time),Dr. Thomas Fox, from the Dana-Farber Cancer Institute & Boston Children’s Hospital, Harvard Medical School and UCL Institute of Immunity ...

⏰ Don't miss the next #CTGCT #ScienceTalks with Dr. Thomas Fox! Explore the future of Programmable T Cell Therapies:

📅 Monday, April 13, 2026 🕒 2:00 PM
ctgct.si/en/objave/ct...

#Biotech #TCell #CRISPR

Join us for the #GeneH & 21st CFGBC Symposium: “From Functional Genomics to Gene Therapy”!

📅3 June 2026
📍Uni. of Ljubljana
💰Free admission
📢Call for Abstracts! Present your research at our poster session.
⏳Deadline: 20 May
cfgbc.mf.uni-lj.si/events/2026cfgbcsym21/
@genehproject.bsky.social

💡 New ERDERA Knowledge Pill! What are ATMPs and how are they changing how we think about treatment, especially for people living with rare diseases?
🔎 Learn more: https://loom.ly/pjOwax0
#ATMPs #AdvancedTherapies #RareDiseases #ERDERA

Got questions? 🤔
🔹 Format: Blended (approx. 8h/week). 🔹 Teams: Max 10 teams. 🔹 Focus: Dedicated to #GeneTherapy translation.
Ready to take the next step? Learn more:https://tinyurl.com/genehpt
#GeneH #GeneTherapyAccelerator #HorizonEurope
@kemijski.bsky.social
@ctgct.bsky.social

CTGCT Science Talks April - Dr. Thomas Fox - CTGCT On Monday, 13th of April 2026, 2:00 PM (Ljubljana/Berlin time),Dr. Thomas Fox, from the Dana-Farber Cancer Institute & Boston Children’s Hospital, Harvard Medical School and UCL Institute of Immunity ...

⏰ Don't miss the next #CTGCT #ScienceTalks with Dr. Thomas Fox! Explore the future of Programmable T Cell Therapies:

📅 Monday, April 13, 2026 🕒 2:00 PM
ctgct.si/en/objave/ct...

#Biotech #TCell #CRISPR

How AI is Helping Us Design the Proteins of the Future - CTGCT Imagine if we could design the "building blocks" of life just like we design a new house or a car. Instead of relying on what nature has given us through millions of years of evolution, what if we cou...

Can AI design the proteins of the future?

In our latest #CTGCT #ScienceTalks, Dr. @ajasjaljubetic.bsky.social showcased how AI is building proteins from scratch, from stable vaccines to microscopic nanorobots.

Check out the breakdown and watch the recording: ctgct.si/en/objave/ai...

🧬 ZOPS (Society helix) represents 45+ patient associations in Slovenia. It strengthens patient engagement and connects patient groups, clinicians and decision-makers. → uc.pt/en/geneh/

#ZOPS
@kemijski.bsky.social @ctgct.bsky.social

🧬 APAHE supports people affected by hereditary ataxias in Portugal, plus families and caregivers. In GeneH, APAHE brings lived-experience insight to strengthen awareness, genetic literacy and patient-centred, ethical approaches. → uc.pt/en/geneh/
@kemijski.bsky.social
@ctgct.bsky.social

Job Openings - CTGCT The work at the Centre for the Technologies of Gene and Cell Therapy is focused on translating research into treatments through innovative strategies, including advanced gene editing, cell-based treat...

📢 We are still hiring at the CTGCT!

🔬 GMP Production & Development Expert (PhD)
🧪 Postdoctoral Researcher

Join our international team advancing innovative therapies for cancer and rare diseases.

🗓 Apply by 29 March 2026
📩 zaposlitev@ki.si
ctgct.si/en/jobs/
#Hiring #ATMP #Biotech

Join us on our next #CTGCT #ScienceTalks with Dr. @Thomas Fox ( @harvardmed.bsky.social / @ucl.ac.uk ) for an exciting talk on "Programmable T Cell Therapies: From Precision Genome Editing to In Vivo Programming"

📅April 13, 2026 | 2:00 PM (CET)
ctgct.si/en/objave/ct...

🧬 We are launching the #GeneTherapyAccelerator, a #GeneH initiative to translate breakthrough research into market-ready therapies.

Save the dates: 📅 April 22 & 29 📅 May 6 & 13
🔗 Apply now: forms.office.com/e/eRWZ2kdz3q

#GeneTherapy #HorizonEurope

@kemijski.bsky.social
@ctgct.bsky.social

🧬 CCDR Centro is the public authority coordinating regional development in Portugal’s Centro Region.

In GeneH, they help align policy priorities and stakeholders to strengthen the ecosystem and enable sustainable collaboration and real-world uptake.

@kemijski.bsky.social
@ctgct.bsky.social

🧠 The Blood–Brain Barrier protects the brain, but also blocks out many medicines. In GeneH Deliverable 5.1, our Joint Research Program advances precision of genetic tools and smart delivery strategies to reach CNS cells. Article: www.uc.pt/en/geneh/new...

@kemijski.bsky.social
@ctgct.bsky.social

CTGCT at the 12th National Rare Disease Day Conference - CTGCT On Friday, February 27, 2026, part of our team joined experts, decision-makers, and patient advocates at the 12th National Rare Disease Day Conference held at the Congress Center Brdo pri Kranju.The e...

The #CTGCT team joined the 12th National Rare Disease Day Conference.
Highlights:
✅ #Urbagen: 1st Slovenian rare disease drug milestone
✅ @genehproject.bsky.social : Proud partners in patient-centric research
✅ Bridging the gap from lab to bedside
ctgct.si/en/objave/12...
#RareDiseaseDay #Slovenia

Remote-Controlling the Cell: The Future of Precision Medicine? - CTGCT Imagine if we could talk to our cells the same way we talk to a smart home device. We could tell a cell to start producing a specific medicine only when it’s needed or order a group of cells to shift ...

Can we "remote-control" our cells?

Researchers led by @rjerala.bsky.social at @kemijski.bsky.social have developed a way to turn genes on/off using human hormone receptors and "lava lamp" physics.

Read more:
ctgct.si/en/objave/re...

#SyntheticBiology

Job Openings - CTGCT The work at the Centre for the Technologies of Gene and Cell Therapy is focused on translating research into treatments through innovative strategies, including advanced gene editing, cell-based treat...

New positions alert! We are #hiring at the #CTGCT. Don't miss this chance to join our team
ctgct.si/en/jobs/

CTGCT Science Talks March - Dr. Ajasja Ljubetič - CTGCT On Monday, 2nd of March 2026, 2:00 PM (Ljubljana/Berlin time),Dr. Ajasja Ljubetič, Research Assistant Processor and group leader in the Department of Synthetic Biology and Immunology at the National I...

Join us on the #CTGCT #Science_Talks #webinar

We’re pleased to host Dr.@ajasjaljubetic.bsky.social from Dept. Syn. Bio and Immuno. at the @kemijski.bsky.social . He will present his work titled “Overview of de novo protein design (and design of novel binders)”.

ctgct.si/en/objave/ct...

Success for #GeneH is a stronger 4-helix ecosystem, closer PT–SI collaboration and concrete examples of gene therapy innovations moving towards patients.

🎥 New video out now: youtu.be/DSkV0_tDEzM
#ResearchToPatients #EUProjects

@kemijski.bsky.social
@ctgct.bsky.social

Today is PUST (carnival) in Slovenia and some of the brave members of the CTGCT dared to come to the office (or WFH) in full costume!

May the #krof be in you, Happy #Pust!

Can you guess all costumes?

Molecular Surgery: How Base Editors are Rewriting the Future of Cancer Therapy - CTGCT Imagine being able to open the "instruction manual" of a human cell and fix a single typo that causes a life-threatening disease. This is no longer science fiction; it is the reality of base editors, ...

Can we "erase" cancer by fixing a single DNA typo?

Dr. Sayed, from @tudresden.bsky.social, is pioneering the use of CRISPR base editors to rewrite mutations in the P53 gene, the "guardian of the genome."

Read how this technology is the future of personalized medicine: ctgct.si/en/objave/mo...

GeneH partners published a new article on Action & Investment Plan. 4-stage roadmap from Discovery → Testing → Scaling up → Clinical trials + tools.

Read more: www.uc.pt/en/geneh/new...

#GeneH #GeneTherapy #HorizonEurope #RareDiseases

@kemijski.bsky.social
@ctgct.bsky.social

Just 3 weeks left to apply for these positions!

Job Openings - CTGCT The work at the Centre for the Technologies of Gene and Cell Therapy is focused on translating research into treatments through innovative strategies, including advanced gene editing, cell-based treat...

New year, new teammates at #CTGCT! 🥼

We are hiring 5 key roles at @kemijski.bsky.social:

🧬 2x GMP Experts: PhD + 4yrs exp. in bioprocess/QA.
🔬 3x Postdoc Researchers: PhD + 3yrs postdoc exp. preferred.

📅 Deadline: Feb 19, 2026
Details: ctgct.si/en/jobs/

#Hiring #GeneTherapy

Job Openings - CTGCT The work at the Centre for the Technologies of Gene and Cell Therapy is focused on translating research into treatments through innovative strategies, including advanced gene editing, cell-based treat...

New year, new teammates at #CTGCT! 🥼

We are hiring 5 key roles at @kemijski.bsky.social:

🧬 2x GMP Experts: PhD + 4yrs exp. in bioprocess/QA.
🔬 3x Postdoc Researchers: PhD + 3yrs postdoc exp. preferred.

📅 Deadline: Feb 19, 2026
Details: ctgct.si/en/jobs/

#Hiring #GeneTherapy

CTGCT Science Talks February - Dr. Shady Sayed - CTGCT On Monday, 2nd of February 2026, 2:00 PM (Ljubljana/Berlin time), Dr. Shady Sayed from the Department of Medical Systems Biology, Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, GermanyFil...

Join us on the #CTGCT #Science_Talks #webinar

We’re pleased to host Dr. Shady El-Husseiny,TU Dresden. He will present his work titled “Application of CRISPR base editors in innovative cancer therapies”.

ctgct.si/en/objave/ct...

Boosting Immunity After Transplantation: The Future of Automated T-Cell Therapy - CTGCT For patients undergoing a life-saving organ transplant, the road to recovery is often a delicate balancing act. While the new organ offers a second chance, the drugs needed to prevent the body from re...

Can automation revolutionize viral defense after transplant? 🧬
At #CTGCT #ScienceTalks, Claudia Beltran Mestres from Charité Berlin shared how automated G-Rex bioreactors produce "fitter" T-cells to fight viral infections after a transplant.

Article: ctgct.si/en/objave/bo...

Ceremonial Signing of the Agreement on Co-Financing of the CTGCT - CTGCT We are proud to announce a historic milestone for our project. On December 22, 2025, the Minister of Higher Education, Science, and Innovation, Dr. Igor Papič, and the Director of the National Institu...

🚀 Big news!

The #CTGCT co-financing agreement is signed. This €30M joint investment (EU + Slovenia) will help translating knowledge into clinical practice.

Led by Dr. Mojca Benčina, we’re: 🔬 Advancing therapies 🥼 Bringing talent home 🤝 Partnering globally

Full story: ctgct.si/en/objave/ce...